Ligence Heart vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Ligence
VS
by Powerful Medical

AI Verdict

These tools are adjacent in their focus on cardiac diagnostics but differ significantly in their input data and specific applications. Ligence Heart specializes in automating the analysis of 2D transthoracic echocardiography for detailed structural and functional assessment, ideal for cardiologists and sonographers. PMcardio, on the other hand, focuses on rapid AI-powered interpretation of ECGs to detect a wide range of cardiac conditions, making it suitable for a broader set of healthcare professionals at the point of care.

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department needs to automate and standardize the analysis and reporting of 2D transthoracic echocardiography. It is ideal for reducing variability in measurements, improving diagnostic efficiency, and freeing up cardiologists and sonographers to focus on patient care rather than manual tasks.

View Ligence Heart →

Choose PMcardio if…

Choose PMcardio if you require rapid, AI-powered interpretation of ECGs for the assessment of over 50 cardiac conditions, especially in acute care or primary care settings where quick, accurate decisions are critical. It is well-suited for emergency physicians, GPs, nurses, and paramedics who need expert-level ECG analysis at the point of care, including detection of STEMI/OMI and reduced LVEF.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ligence Heart PMcardio
Pricing Contact-for-pricing Freemium
Deployment Cloud-based; on-premise; hybrid Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart emphasizes an intuitive, user-friendly interface designed to resemble programs clinicians use daily, aiming to reduce the learning curve and streamline workflow by automating measurements and reporting. PMcardio, while offering a mobile app for accessibility and quick analysis, has received some user feedback regarding initial difficulties with certain features and a paywall for advanced functionalities.

Clinical Value

PMcardio

PMcardio boasts extensive clinical validation with over 25 studies, demonstrating superior accuracy in detecting over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, and has shown to reduce false STEMI alarms. Ligence Heart also has published studies validating its automated measurements against human experts and CT scans, with claims of outperforming humans in some echocardiography tasks. However, PMcardio's broader range of detectable conditions and numerous validation studies give it an edge in overall clinical value.

Pricing & Value

PMcardio

PMcardio offers a freemium model with 5 free ECG analyses per month, allowing individual clinicians to experience the tool before committing to a paid plan. Ligence Heart's pricing is available upon contact, suggesting an enterprise-quote model without a publicly available free trial or transparent individual pricing. This makes PMcardio more accessible for individual users and offers a clear pathway to evaluate its value.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Ligence Heart offers cloud-based, on-premise, and hybrid deployment options and integrates with existing PACS, EHR, and RIS systems. PMcardio also provides enterprise integrations with EHR/CVIS and EMS systems, offers regional data residency options, and has SOC 2 Type II and ISO 27001 certifications. Both are designed for seamless integration into hospital workflows and adhere to high security and compliance standards.

Innovation

PMcardio

PMcardio stands out with its 'Queen of Hearts' STEMI and OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability with heatmaps, offering novel features for enhanced diagnostic confidence and learning. Ligence Heart focuses on automating echocardiography analysis and reporting, which is innovative in streamlining workflow and improving accuracy. However, PMcardio's specific explainability features and broader range of AI-powered detections from ECGs demonstrate a slightly higher degree of innovation in its offerings.

Support & Docs

PMcardio

PMcardio provides a dedicated Help Center with instructions for use, FAQs, and articles on various features, available in multiple languages. They also offer in-app support chat and actively respond to user feedback on app stores. While Ligence emphasizes user-centric design and feedback integration, specific details on their public-facing support documentation are less prominent than PMcardio's comprehensive resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ligence Heart PMcardio
Name Ligence Heart PMcardio
Description AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Company Ligence Powerful Medical
Tagline Echocardiography that makes sense. AI that reads ECGs in seconds
Categories Cardiology AI Cardiology AI, Clinical Decision Support & Reference
Key Features Automated recognition of echocardiography imaging data, Automated view classification and heart phase prediction, Automated calculation of measurements and report generation, Transfer of echocardiography images (PHI removed) from hospital PACS, Area, Distance, Doppler, and Volume quantification, Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), Automated strain, Spectral and Tissue Doppler measurements, Integration with existing systems (PACS, EHR, RIS) Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Ligence Heart is designed to integrate seamlessly with existing PACS and EHR systems, automating echocardiography analysis and report generation to streamline workflows for cardiologists. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, aiming to connect to existing ECG systems and other hospital IT systems for automated result flow and care coordination. PMcardio also allows for the export of detailed PDF reports for integration into patient EHRs.
Ligence Heart automates echocardiography image evaluation with non-inferior accuracy compared to cardiologists and reduces intra-rater variability of measurements. Studies have shown Ligence Heart's AI closely matches expert cardiologist readings for aortic dimensions and can outperform humans in echocardiography measurements when compared to CT scans. PMcardio has been clinically validated in over 25 studies, demonstrating high sensitivity and specificity for various ECG abnormalities. For example, it showed 86% sensitivity and 92% specificity for major ECG abnormalities, and 97% sensitivity and 99% specificity for Atrial Fibrillation in a primary care setting. PMcardio's Queen of Hearts platform for STEMI detection has shown better sensitivity (92% vs 71%) and specificity (81% vs 29%) than standard processes.
Ligence Heart is specifically designed for cardiologists and sonographers, focusing on automating the analysis and reporting of 2D transthoracic echocardiography to enhance diagnostic efficiency and accuracy for conditions like heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases. PMcardio is suitable for a broader range of healthcare professionals including cardiologists, emergency medicine physicians, and internal medicine specialists, interpreting ECGs to assess over 50 cardiac conditions rapidly and accurately, including STEMI/OMI, reduced LVEF, and various arrhythmias.
Ligence Heart is characterized by its ease of use and intuitive interface, suggesting that healthcare professionals can become proficient with little practice. PMcardio is designed to seamlessly integrate into fast-paced clinical routines, with features like automated ECG digitization and format detection to streamline workflows. Both tools aim to simplify complex diagnostic tasks, implying a reduced learning curve.
Ligence provides customer service via email and has an Information Security Officer contact available. PMcardio offers email/help desk support, live online training sessions, and documentation. They also have a help center, FAQs, and publications available on their website.
PMcardio for Organizations supports full audit trails, allowing for tracking pathway performance across sites and teams, and using dashboards and reporting for QA and audits. While Ligence Heart's description does not explicitly mention audit-trail features, it focuses on automated report generation and measurements, which typically include a record of the analysis performed.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.